Cargando…
Peroxisome Proliferator-Activated Receptor-Gamma Agonists Suppress Tissue Factor Overexpression in Rat Balloon Injury Model with Paclitaxel Infusion
The role and underlying mechanisms of rosiglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-γ) agonist, on myocardial infarction are poorly understood. We investigated the effects of this PPAR-γ agonist on the expression of tissue factor (TF), a primary molecule for thrombosis, and...
Autores principales: | Park, Jun-Bean, Kim, Baek-Kyung, Kwon, Yoo-Wook, Muller, Dominik N., Lee, Hyun-Chae, Youn, Seock-Won, Choi, Young-Eun, Lee, Sae-Won, Yang, Han-Mo, Cho, Hyun-Jai, Park, Kyung Woo, Kim, Hyo-Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3226685/ https://www.ncbi.nlm.nih.gov/pubmed/22140576 http://dx.doi.org/10.1371/journal.pone.0028327 |
Ejemplares similares
-
A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer
por: Kim, Jung Sun, et al.
Publicado: (2022) -
COMP-Angiopoietin-1 accelerates muscle regeneration through N-cadherin activation
por: Youn, Seock-Won, et al.
Publicado: (2018) -
Rosiglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Restores Alveolar and Pulmonary Vascular Development in a Rat Model of Bronchopulmonary Dysplasia
por: Lee, Hyun Ju, et al.
Publicado: (2014) -
Weekly Paclitaxel and Trastuzumab as a First-Line Therapy in Patients with HER2-Overexpressing Metastatic Breast Cancer: Magnitude of HER2/neu Amplification as a Predictive Factor for Efficacy
por: Han, Hye-Suk, et al.
Publicado: (2009) -
Deficiency of peroxisomal NUDT7 stimulates de novo lipogenesis in hepatocytes
por: Song, Jinsoo, et al.
Publicado: (2022)